Metformin Vitabalans 1000 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin vitabalans 1000 mg filmsko obložene tablete

vitabalans oy - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin

Metformin Vitabalans 500 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin vitabalans 500 mg filmsko obložene tablete

vitabalans oy - metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin

Metformin Vitabalans 1000 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin vitabalans 1000 mg filmsko obložene tablete

vitabalans oy - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin

Metformin Alkaloid-INT 500 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin alkaloid-int 500 mg filmsko obložene tablete

metformin - filmsko obložena tableta - metformin 390 mg / 1 tableta - metformin

Metformin Alkaloid-INT 850 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin alkaloid-int 850 mg filmsko obložene tablete

metformin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta - metformin

Metformin/glibenklamid Lek 500 mg/2,5 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin/glibenklamid lek 500 mg/2,5 mg filmsko obložene tablete

lek d.d. - glibenklamid; metformin - filmsko obložena tableta - glibenklamid 2,5 mg / 1 tableta  metformin390 mg / 1 tableta; metformin 390 mg / 1 tableta - metformin in sulfonilsečnine

Metformin/glibenklamid Lek 500 mg/5 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin/glibenklamid lek 500 mg/5 mg filmsko obložene tablete

lek d.d. - glibenklamid; metformin - filmsko obložena tableta - glibenklamid 5 mg / 1 tableta  metformin390 mg / 1 tableta; metformin 390 mg / 1 tableta - metformin in sulfonilsečnine

Metformin Lek 1000 mg filmsko obložene tablete Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin lek 1000 mg filmsko obložene tablete

lek d.d. - metformin - filmsko obložena tableta - metformin 780 mg / 1 tableta - metformin

Vildagliptin / Metformin hydrochloride Accord Europese Unie - Sloveens - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Sitagliptin / Metformin hydrochloride Accord Europese Unie - Sloveens - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , trojna kombinacija terapija), kot dodatek k prehrani in vadbi pri bolnikih neustrezno nadzorovano na maksimalno dopustne odmerek metforminom in sulfonil sečnine. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.